Affitech As
Records under this name other than patents Affitech As holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,394,943 | Anti-VEGF antibody compositions and methods Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,034,905 | Anti-VEGF antibody compositions and methods Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,268,314 | Bispecific ANTI-VEGF/ANTI-ANG-2 Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 9,421,256 | Anti-VEGF antibody compositions and methods Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 6,822,075 | Protein L and hybrid proteins thereof Term ended Term ended Nov 23, 2021 · From the USPTO record | Term ended | Term ended Nov 23, 2021 | From the USPTO record |
| US 7,838,637 | Single-chain multiple antigen-binding molecule, its preparation and use Formerly held Term ended Term ended Apr 27, 2021 · From the USPTO record | Term ended | Term ended Apr 27, 2021 | From the USPTO record |
| US 6,884,629 | Immunoglobulin binding protein Term ended Term ended Jan 19, 2020 · From the USPTO record | Term ended | Term ended Jan 19, 2020 | From the USPTO record |
| US 6,380,365 | Temperature dependent ligand facilitated purification of proteins Term ended Term ended May 5, 2019 · From the USPTO record | Term ended | Term ended May 5, 2019 | From the USPTO record |
| US 6,759,518 | Single-chain multiple antigen-binding molecule, its preparation and use Formerly held Term ended Term ended Apr 9, 2019 · From the USPTO record | Term ended | Term ended Apr 9, 2019 | From the USPTO record |
| US 6,162,903 | Immunoglobulin binding proteins derived from L protein and their uses Term ended Term ended Dec 19, 2017 · From the USPTO record | Term ended | Term ended Dec 19, 2017 | From the USPTO record |